Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation.
about
Recent insights in the pathogenesis of post-transplantation lymphoproliferative disordersEpstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infectionEpstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines.To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesisTRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway ActivationA Viral microRNA Cluster Regulates the Expression of PTEN, p27 and of a bcl-2 HomologEpigenetic silencing of tumor suppressor genes during in vitro Epstein-Barr virus infection.Virus-Mediated Alterations in miRNA Factors and Degradation of Viral miRNAs by MCPIP1.Metabolic stress is a barrier to Epstein-Barr virus-mediated B-cell immortalization.Limited but durable changes to cellular gene expression in a model of latent adenovirus infection are reflected in childhood leukemic cell lines.Epstein-Barr virus induces global changes in cellular mRNA isoform usage that are important for the maintenance of latency.Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2.Evolutionary conservation of primate lymphocryptovirus microRNA targetsDynamic Epstein-Barr virus gene expression on the path to B-cell transformation.EBV Noncoding RNAs.Epstein-Barr virus latency: current and future perspectives.Recent advances in understanding Epstein-Barr virus.Expression and Regulation of the Endogenous Retrovirus 3 in Hodgkin's Lymphoma Cells.Analysis of host gene expression changes reveals distinct roles for the cytoplasmic domain of the Epstein-Barr virus receptor/CD21 in B-cell maturation, activation, and initiation of virus infection.Epstein-Barr Virus LMP1 Mediated Oncogenicity.EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features.Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.Mitogen-induced B-cell proliferation activates Chk2-dependent G1/S cell cycle arrestEarly gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases.Epstein-Barr Virus Induces Adhesion Receptor CD226 (DNAM-1) Expression during Primary B-Cell Transformation into Lymphoblastoid Cell Lines.Epstein-Barr Virus Hijacks DNA Damage Response Transducers to Orchestrate Its Life Cycle.c-Myc Represses Transcription of the Epstein-Barr Virus Latent Membrane Protein 1 Early After Primary B Cell Infection.EBV and Apoptosis: The Viral Master Regulator of Cell Fate?CRISPR-Cas9 Genetic Analysis of Virus-Host Interactions.Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome.Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity.EBV persistence without its EBNA3A and 3C oncogenes in vivo.An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model
P2860
Q28075701-C2E24D5D-FC47-415D-888C-B304D2197E93Q33658144-4338B126-F38E-42B0-A6A1-5FE281708923Q35115666-47543F28-C3F6-4EE3-A07A-64E55FC7DD5FQ35581465-E3FE1399-BF5D-4CA5-B19C-B499CF4A7574Q35634395-5A3DD59C-8E8D-4FEB-9EFE-D7692152F864Q35901611-E4792D52-0386-4AD7-91E2-5C82786EF1A8Q36079181-2B652A30-81F1-4F1C-9D3B-D44A1D397854Q36205470-61FDC6D5-C5DE-4CA8-BA6C-A10A0ED5FD30Q36598911-2DBC75AF-3F0D-42A2-9969-3CD456E4E957Q37097260-5AEAA9E8-ED31-4DA2-A9BC-85B351B434BDQ37254393-E6FF2714-0FD5-4A7F-A55A-3BCD4C2AA71FQ37319836-F82B2CDE-DB8A-4014-939B-3BA7E750715EQ37547327-649744F9-03AA-4CDB-BFDE-02FEF420054DQ38174306-8EACD2D3-98BA-46BB-BF40-E081C676C11EQ38597243-E2F600DD-C1CA-4C6A-B606-972D545C8AD0Q38603533-2FD38255-598F-4E6A-A9B7-19ABF0BFF822Q39241944-B900EA6F-7E7A-4B2A-A5EA-0EE7F5AEB143Q39386056-8EFFBE42-0B56-4657-96F3-E2CF6FC450F3Q39547392-E7E77AB1-6931-44AF-B9E5-3EC4FBAE08BAQ40073030-9552688A-575F-420D-A7CB-831FD6AD4022Q40094003-C1BD5451-D97F-4F7F-B60D-0228D3E3977FQ40375799-12A92460-CCDD-4BE1-91E4-47E730ABF321Q41901371-DC599715-BEC7-4848-8AE4-14512D705FF2Q42264347-8D53AE4C-E1B7-435E-B1D8-9EBB3A44437EQ44877602-E2166FFE-A02C-453D-8B58-535D107CAD93Q45324762-CDEB3458-4491-45DB-A222-F09820A3611EQ45325105-ABB4B9CB-8D73-47AF-99BB-4C103E9EA08CQ47117102-07C9B49C-0F3F-4E13-AD6B-D32F4CC4EC5EQ47547574-0BE2F3D3-8C9B-4173-86AB-CFC5545C74E9Q50535712-F6F0B69A-1A60-411F-BA29-DFA2BA03F075Q52319664-8773D2F2-32B9-4DBE-A0D3-4B18DB234985Q52803943-4CD79E82-AFCA-4AC5-AC71-BEDE2FCF7EEAQ57025486-58F35802-564D-4CE1-869C-B7422BD4F32C
P2860
Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Analysis of Epstein-Barr virus ...... n 1-mediated NF-κB activation.
@en
Analysis of Epstein-Barr virus ...... n 1-mediated NF-κB activation.
@nl
type
label
Analysis of Epstein-Barr virus ...... n 1-mediated NF-κB activation.
@en
Analysis of Epstein-Barr virus ...... n 1-mediated NF-κB activation.
@nl
prefLabel
Analysis of Epstein-Barr virus ...... n 1-mediated NF-κB activation.
@en
Analysis of Epstein-Barr virus ...... n 1-mediated NF-κB activation.
@nl
P2093
P2860
P356
P1433
P1476
Analysis of Epstein-Barr virus ...... n 1-mediated NF-κB activation.
@en
P2093
Alexander M Price
Eleonora Forte
Jason P Tourigny
Micah A Luftig
Raul E Salinas
Sandeep S Dave
P2860
P304
11096-11106
P356
10.1128/JVI.01069-12
P407
P577
2012-08-01T00:00:00Z